Fintel reports that on April 13, 2023, Maxim Group upgraded their outlook for ContraFect (NASDAQ:CFRX) from Hold to Buy .
https://www.nasdaq.com/articles/maxim-group-upgrades-contrafect-cfrx
Fintel reports that on April 13, 2023, Maxim Group upgraded their outlook for ContraFect (NASDAQ:CFRX) from Hold to Buy .
https://www.nasdaq.com/articles/maxim-group-upgrades-contrafect-cfrx
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.